Hicks Jane Kennedy
Known title: EVP & Managing DirectorCIK: 0001830534
Associated companies
Transaction History
| CUZ | ▼ Sell | Tax Withholding | 6,235 | $140K | 2/17/2026 | View on chart |
| CUZ | ▲ Buy | Grant | 21,371 | $480K | 2/13/2026 | View on chart |
| CUZ | ▲ Buy | Grant | 20,679 | $514K | 2/2/2026 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 4,161 | $125K | 2/16/2025 | View on chart |
| CUZ | ▲ Buy | Grant | 14,090 | $422K | 2/14/2025 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 644 | $20K | 1/31/2025 | View on chart |
| CUZ | ▲ Buy | Grant | 10,711 | $327K | 1/31/2025 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 1,829 | $43K | 2/16/2024 | View on chart |
| CUZ | ▲ Buy | Grant | 15,671 | $370K | 2/16/2024 | View on chart |
| CUZ | ▲ Buy | Grant | 7,280 | $159K | 2/5/2024 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 1,027 | $23K | 2/1/2024 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 1,041 | $24K | 1/31/2024 | View on chart |
| CUZ | ▲ Buy | Grant | 12,232 | $320K | 2/16/2023 | View on chart |
| CUZ | ▲ Buy | Grant | 8,150 | $215K | 2/6/2023 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 2,459 | $65K | 2/6/2023 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 292 | $8K | 2/3/2023 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 725 | $20K | 2/2/2023 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 735 | $20K | 2/1/2023 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 253 | $10K | 2/4/2022 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 311 | $12K | 2/3/2022 | View on chart |
| CUZ | ▼ Sell | Tax Withholding | 725 | $28K | 2/1/2022 | View on chart |
| CUZ | ▲ Buy | Grant | 6,224 | $0 | 1/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
CUZ featured in value-stock comparison with NHI
A recent Yahoo Finance article compared Cousins Properties with National Health Investors as two candidates for value-focused portfolios. The piece highlights CUZ's elevated trailing P/E of 763.4 alongside a 6.47% dividend yield, framing the discussion around income versus valuation. With 11 analysts covering the stock and an average target of $33.64 against a 52-week range of $21.03 to $32.95, the comparison offers one snapshot for readers weighing these names side by side.
CUZ featured in value-stock comparison with NHI. A recent Yahoo Finance article compared Cousins Properties with National Health Investors as two candidates for value-focused portfolios. The piece highlights CUZ's elevated trailing P/E of 763.4 alongside a 6.47% dividend yield, framing the discussion around income versus valuation. With 11 analysts covering the stock and an average target of $33.64 against a 52-week range of $21.03 to $32.95, the comparison offers one snapshot for readers weighing these names side by side.